ZWJ Investment Counsel Inc. Boosts Stake in Colgate-Palmolive (NYSE:CL)

ZWJ Investment Counsel Inc. increased its position in Colgate-Palmolive (NYSE:CLFree Report) by 11.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 3,881 shares of the company’s stock after purchasing an additional 388 shares during the period. ZWJ Investment Counsel Inc.’s holdings in Colgate-Palmolive were worth $353,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter worth about $42,000. Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive during the third quarter worth approximately $53,000. Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive during the third quarter worth approximately $64,000. True Wealth Design LLC increased its stake in Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC increased its stake in Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after acquiring an additional 368 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.37% of the stock is owned by company insiders.

Colgate-Palmolive Stock Down 0.5 %

Colgate-Palmolive stock opened at $88.27 on Wednesday. The business has a fifty day moving average of $92.13 and a two-hundred day moving average of $97.71. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a market cap of $72.12 billion, a P/E ratio of 25.29, a P/E/G ratio of 3.62 and a beta of 0.44. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.27%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Analyst Ratings Changes

Several equities research analysts have weighed in on CL shares. TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Stifel Nicolaus cut their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $101.11.

Read Our Latest Stock Analysis on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.